474 related articles for article (PubMed ID: 22763567)
1. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
Georgi E; Schacht E; Scholz HC; Splettstoesser WD
J Antimicrob Chemother; 2012 Oct; 67(10):2429-33. PubMed ID: 22763567
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe.
Kreizinger Z; Makrai L; Helyes G; Magyar T; Erdélyi K; Gyuranecz M
J Antimicrob Chemother; 2013 Feb; 68(2):370-3. PubMed ID: 23065699
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
Kiliç S; Celebi B; Acar B; Ataş M
Scand J Infect Dis; 2013 May; 45(5):337-41. PubMed ID: 23249114
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey.
Yesilyurt M; Kiliç S; Celebi B; Celik M; Gül S; Erdogan F; Ozel G
J Antimicrob Chemother; 2011 Nov; 66(11):2588-92. PubMed ID: 21856791
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
Caspar Y; Hennebique A; Maurin M
J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
Tomaso H; Al Dahouk S; Hofer E; Splettstoesser WD; Treu TM; Dierich MP; Neubauer H
Int J Antimicrob Agents; 2005 Oct; 26(4):279-84. PubMed ID: 16143497
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents.
García del Blanco N; Gutiérrez Martín CB; de la Puente Redondo VA; Rodríguez Ferri EF
Res Vet Sci; 2004 Jun; 76(3):195-8. PubMed ID: 15046952
[TBL] [Abstract][Full Text] [Related]
9. Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.
Caspar Y; Sutera V; Boisset S; Denis JN; Maurin M
Front Cell Infect Microbiol; 2014; 4():24. PubMed ID: 24579066
[TBL] [Abstract][Full Text] [Related]
10. [Determination of the Subspecies of Francisella tularensis Isolated in Turkey by Molecular Methods].
Çelebi B; Bakkaloğlu Z; Ünaldı Ö; Karagöz A; Kılıç S; Durmaz R
Mikrobiyol Bul; 2020 Jan; 54(1):1-10. PubMed ID: 32050874
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of a new group of Francisella tularensis subsp. holarctica in Switzerland with altered antimicrobial susceptibilities, 1996 to 2013.
Origgi FC; Frey J; Pilo P
Euro Surveill; 2014 Jul; 19(29):. PubMed ID: 25080140
[TBL] [Abstract][Full Text] [Related]
12. Differential Substrate Usage and Metabolic Fluxes in
Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
[No Abstract] [Full Text] [Related]
13.
Caspar Y; Maurin M
Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Antimicrobial Susceptibilities of
Martínez-Martínez S; Rodríguez-Ferri EF; Rodríguez-Lázaro D; Hernández M; Gómez-Campillo JI; Martínez-Nistal MDC; Fernández-Natal MI; García-Iglesias MJ; Mínguez-González O; Gutiérrez-Martín CB
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438988
[TBL] [Abstract][Full Text] [Related]
15. [In Vitro Activity of Tigecycline Against Francisella tularensis Subsp. holarctica in Comparison with Doxycycline, Ciprofloxacin and Aminoglycosides].
Ulu Kılıç A; Kılıç S; Celebi B; Sencan I
Mikrobiyol Bul; 2013 Jan; 47(1):189-91. PubMed ID: 23390918
[TBL] [Abstract][Full Text] [Related]
16. Genetic Diversity and Spatial Segregation of
Appelt S; Köppen K; Radonić A; Drechsel O; Jacob D; Grunow R; Heuner K
Front Cell Infect Microbiol; 2019; 9():376. PubMed ID: 31781515
[No Abstract] [Full Text] [Related]
17. [Francisella tularensis and tularemia in Turkey].
Gürcan S
Mikrobiyol Bul; 2007 Oct; 41(4):621-36. PubMed ID: 18173084
[TBL] [Abstract][Full Text] [Related]
18. Description of Francisella hispaniensis sp. nov., isolated from human blood, reclassification of Francisella novicida (Larson et al. 1955) Olsufiev et al. 1959 as Francisella tularensis subsp. novicida comb. nov. and emended description of the genus Francisella.
Huber B; Escudero R; Busse HJ; Seibold E; Scholz HC; Anda P; Kämpfer P; Splettstoesser WD
Int J Syst Evol Microbiol; 2010 Aug; 60(Pt 8):1887-1896. PubMed ID: 19783615
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method.
Valade E; Vaissaire J; Mérens A; Hernandez E; Gros C; Le Doujet C; Paucod JC; Thibault FM; Durand B; Lapalus M; Dupuis I; Caclard A; Vidal DR; Cavallo JD
J Antimicrob Chemother; 2008 Jul; 62(1):208-10. PubMed ID: 18397924
[No Abstract] [Full Text] [Related]
20. Broth microdilution susceptibility testing of Francisella tularensis: quality control limits for nine antimicrobial agents and three standard quality control strains.
Brown SD; Krisher K; Traczewski MM
J Clin Microbiol; 2004 Dec; 42(12):5877-80. PubMed ID: 15583330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
